Post-Marketing Drug Withdrawals: A Review
Authors:
- 1 October 2023
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 57 (7) , 1138-1146
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cancer and fertility preservation: international recommendations from an expert meetingBMC Medicine, 2016
- WITHDRAWN—a resource for withdrawn and discontinued drugsNucleic Acids Research, 2015
- Clinical Association Between Pharmacogenomics and Adverse Drug ReactionsDrugs, 2015
- Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysisBMC Medicine, 2015
- Factors affecting the development of adverse drug reactions (Review article)Saudi Pharmaceutical Journal, 2014
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- Role of pharmacogenomics in drug discovery and developmentIndian Journal of Pharmacology, 2008
- “Black box” 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/riskJournal of Allergy and Clinical Immunology, 2006
- The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and ChildrenNeuropsychopharmacology, 2005
- Potential Role of Pharmacogenomics in Reducing Adverse Drug ReactionsJAMA, 2001